Bayer opens new Research & Innovation Center in Boston-Cambridge demonstrating its commitment to precision oncology
Berlin / Boston, June 29, 2022 - Bayer AG announced today the opening of its new Research and Innovation Center ...
Read more
Tag: Bayer
Bayer completes sale of its Environmental Science Professional business to Cinven
Leverkusen, October 5, 2022 – Bayer has completed the sale of its Environmental Science Professional business to the international private ...
Read more
Bayer initiates landmark Phase III study program to investigate oral FXIa inhibitor asundexian
Not intended for U.S. and UK Media Berlin, August 28, 2022 – Bayer announced today the start of a Phase ...
Read more
Bayer supports demining in Ukraine with donation to non-profit “Fondation suisse de déminage”
Leverkusen, August 18, 2022 – Bayer supports the humanitarian non-profit organization “Fondation suisse de déminage” (FSD) in their mission to ...
Read more
Bayer recognized as leader on climate change for fifth consecutive year
14 December 2022 | 15:00 PM Europe/Amsterdam Summary Bayer receives the highest CDP score for its activities and transparency in ...
Read more
Bayer supports rebuilding of Ukrainian healthcare system by donating 1.3 million euros
Leverkusen, November 29, 2022 – Bayer supports rebuilding of the Ukrainian healthcare system with a donation of 1.3 million euros ...
Read more
Bayer receives positive CHMP opinion for Eylea™ in the EU for treatment of preterm infants with retinopathy of prematurity
Not intended for U.S. and UK Media Berlin, November 11, 2022 – The Committee for Medicinal Products for Human Use ...
Read more
Bayer with continued strong performance
Leverkusen, November 8, 2022 – The Bayer Group maintained its strong business performance across all three divisions in the third ...
Read more
Bayer expands development program for elinzanetant with Phase III study in breast cancer patients with vasomotor symptoms caused by endocrine therapy
Not intended for U.S. and UK Media Study plans to investigate elinzanetant as non-hormonal treatment for vasomotor symptoms caused by ...
Read more
“Bayer has excellent prospects for the future”
Leverkusen, April 28, 2023 – Bayer strengthened its position as a successful life science company in 2022 despite the difficult ...
Read more
The Earth News is an independent English-language daily published Website from all around the World News